NCT03796715View on ClinicalTrials.gov

Red Cell Distribution Width Versus Presepsin (Soluble CD14) as a Prognostic Marker in Critically-ill Sepsis Patients

CompletedOBSERVATIONAL

Enrollment

200

Participants

Timeline

Start Date

August 1, 2018

Primary Completion Date

November 20, 2018

Study Completion Date

December 24, 2018

Conditions

Sepsis

Interventions

DIAGNOSTIC_TEST

Red Cell Distribution Width (RDW)

A total of 100 sepsis patients, Red Cell Distribution Width (RDW) was used as prognostic marker.

DIAGNOSTIC_TEST

Presepsin (sCD14-ST)

: A total of 100 sepsis patients, Presepsin (sCD14-ST) was used as prognostic marker.

Trial Locations (1)

11591

Ain Shams University Hospitals, Cairo

All Listed Sponsors

lead

Ain Shams University

OTHER

NCT03796715 - Red Cell Distribution Width Versus Presepsin (Soluble CD14) as a Prognostic Marker in Critically-ill Sepsis Patients | Biotech Hunter | Biotech Hunter